Ethical considerations in the testing of biopharmaceuticals for adventitious agents.
D001688:Biological Products; D003219:Confidentiality; D016265:Conflict of Interest; D030881:Disclosure; D004340:Drug Contamination; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D004467:Economics; D004991:Ethics, Institutional; D005069:Evaluation Studies as Topic; D033161:Government Regulation; D017408:Guidelines as Topic; D006801:Humans; D007753:Laboratories; D004364:Pharmaceutical Preparations; D012306:Risk; D012926:Social Control, Formal; D014481:United States
Biomedical and Behavioral Research; Health Care and Public Health